Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11565027
Hydrogel membrane for adhesion prevention
granted -
US 11566255
Expression of PEDV sequences in plants and plant produced vaccine for same
granted -
US 11555060
QTY FC fusion water soluble receptor proteins
granted -
US 11554140
Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
granted -
US 11547718
Modulators of FOXP3 expression
granted -
US 11549112
RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use
granted -
US 11542302
Modulators of melanocortin receptors for the treatment of depression and anxiety
granted -
US 11535849
Modulation of transthyretin expression
granted -
US 11529427
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11529373
Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage
granted -
US 11529417
Wound healing through sirt1 overexpression
granted -
US 11530411
Methods for reducing LRRK2 expression
granted -
US 11529381
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
granted -
US 11525136
Modulators of APOL1 expression
granted -
US 11524985
IL-37 fusion protein and methods of making and using same
granted -
US 11519007
Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy
granted -
US 11517569
Vilazodone inclusion complexes, compositions and preparation thereof
granted -
US 11505604
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 11497713
Combination taxoid nanoemulsion with immunotherapy in cancer
granted -
US 11492624
RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1
granted -
US 11492345
Compounds and their methods of use
granted -
US 11490643
Lactobacillus casei for treating obesity and associated metabolic disorders
granted -
US 11492388
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
granted -
US 11479770
Use of p38 inhibitors to reduce expression of DUX4
granted